Company intelligence / Profile preview
Arum Therapeutics
Seoul, South Koreaarumtherapeutics.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
The company is developing several preclinical candidates including Chk2 inhibitors for cancer indications and antiviral agents for respiratory conditions.
- Therapeutic areas
- OncologyPulmonologyRare Diseases
- Modalities
- Small molecule drugsChemical drugs
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Collaborative Drug Discovery (CDD Vault implementation)
Beyond the preview
Go deeper on Arum Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Arum Therapeutics.